Showing results (11-20 of 132) with videos related to
Sort By:
Pageof 14
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 19, 2007
An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy modelMichihiko Iijima, Shigeyuki ChakiPeptides|June 28, 2005
Involvement of melanocortin-4 receptor in anxiety and depressionShigeyuki Chaki, Shigeru OkuyamaBehavioural Brain Research|June 10, 2014
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in ratsHiroyuki Koike, Shigeyuki ChakiThe Open Medicinal Chemistry Journal|December 17, 2010
Metabotropic glutamate receptors: potential drug targets for psychiatric disordersAkito Yasuhara, Shigeyuki ChakiCurrent Opinion in Pharmacology|February 28, 2018
mGlu receptors as potential targets for novel antidepressantsShigeyuki Chaki, Kenichi FukumotoPharmacology, Biochemistry, and Behavior|March 3, 2005
Anxiolytic-like effect of a selective and non-peptidergic melanocortin 4 receptor antagonist, MCL0129, in a social interaction testToshiharu Shimazaki, Shigeyuki ChakiPharmaceuticals (Basel, Switzerland)|September 23, 2015
Potential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsShigeyuki Chaki, Kenichi FukumotoCurrent Neuropharmacology|July 26, 2008
Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsYukihiko Shirayama, Shigeyuki ChakiPharmacology, Biochemistry, and Behavior|December 20, 2005
Separation-induced ultrasonic vocalization in rat pups: further pharmacological characterizationMichihiko Iijima, Shigeyuki ChakiPharmacology, Biochemistry, and Behavior|October 25, 2025
Dual orexin receptor antagonists in insomnia: Toward a new therapeutic paradigmShigeyuki Chaki, Yumiko ImaderaPageof 14